AN 783 Pill - green & yellow capsule/oblong, 14mm
Pill with imprint AN 783 is Green & Yellow, Capsule/Oblong and has been identified as Memantine Hydrochloride Extended-Release 14 mg. It is supplied by Amneal Pharmaceuticals LLC.
Memantine is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 14 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AN 783
Memantine Hydrochloride Extended-Release
- Imprint
- AN 783
- Strength
- 14 mg
- Color
- Green & Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 65162-0783
- Inactive Ingredients
-
silicon dioxide,
ethylcellulose,
hypromelloses,
sucrose,
corn starch,
magnesium silicate,
triethyl citrate,
D&C Yellow No. 10,
gelatin,
ferric oxide yellow,
titanium dioxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
ferrosoferric oxide,
butyl alcohol,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Related images for "AN 783"
More about memantine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (90)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
- Memantine drug information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
Other brands
Professional resources
- Memantine monograph
- Memantine (FDA)
- Memantine ER Tablets (FDA)
- Memantine ER capsules (FDA)
- Memantine Oral Solution (FDA)
- Memantine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
